EXEL - Prakiraan gabungan firma investasi Exelixis Inc

Exelixis, Inc. (EXEL) generates revenue from the sale of a high-demand antitumor agent that ensures strong free cash flow, while strictly adhering to environmental waste disposal regulations. This daily price chart on the GURU.Markets platform captured the indicator 55.41. Further development relies on expanding the R&D portfolio and resolving patent legal disputes, although current earnings remain within a safe range.

EXEL Bagan rega target exelixis.com (04.07.2022 - 22.10.2026)

Rincian metrik lan analitis perusahaan Exelixis Corp (EXEL)

Ringkesan indikator lan parameter pambiji Exelixis, Inc. (EXEL):

Rega bursa exelixis.com|EXEL - Target konsensus|Kapitalisasi pasar Exelixis Corp

Analisis umum perusahaan:EXEL (exelixis.com)

The assessment of operational asset strength is based on the average target price of analyst coverage, which aggregates projected stock values from leading investment banks to determine fair market value. For Exelixis, Inc. (EXEL), the stagnation of this metric may signal a reassessment of risks, as geopolitical barriers and the severance of international scientific ties hinder clinical trials, casting doubt on the sustainability of the business's capitalization growth.

Pesaing Exelixis, Inc.

GMAB - Rata-rata rega prakiraan|Nuvalent - Target konsensus|KYMR: Prakiraan gabungan firma investasi|IDEAYA Bio - Prakiraan konsensus analis|Rata-rata rega prakiraan Enliven Corp|ORIC Pharmaceuticals (ORIC) - Bagan rega target|RLAY (relaytx.com) - Bagan rega target|Bagan rega target Nurix Therapeutics, Inc.|Rata-rata rega prakiraan Tyra Biosciences Inc TYRA|Bagan rega target Verastem Inc (VSTM)|Monte Rosa Corp - Prakiraan gabungan firma investasi|Prakiraan konsensus analis CGEM (Cullinan Therapeutics)|IMRX - Target konsensus|CCCC - Bagan rega target|Rata-rata rega prakiraan Black Diamond Therapeutics, Inc.|Repare Rx (RPTX) - Bagan rega target|PMVP (PMV Pharmaceuticals, Inc) - Bagan rega target|Bagan rega target Karyopharm Therapeutics, Inc.|Rata-rata rega prakiraan Propanc Biopharma, Inc. PPCB|Prakiraan konsensus analis BGMS|aadibio.com (AADI) - Rentang target analis|Aileron Therapeutics, Inc. - Target konsensus|Blueprint Medicines Corp. (BPMC) - Rata-rata rega prakiraan|GLYC: Target konsensus|Konsensus nilai wajar SWTX (springworkstx.com)